Intercept Pharmaceuticals

Pharmaceuticals & Biotech

Intercept Pharmaceuticals Careers, Pay and Expert Network

lightbulbWhat are the highest paying jobs at Intercept Pharmaceuticals?

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC), non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea. The companys lead product is Obeticholic acid, OCA, also known as 6-ethyl-chenodeoxycholic acid or INT-747. OCA is a potent first-in-class farnesoid X receptor (FXR) agonist. It is currently in phase III studies for primary biliary cirrhosis, and phase II studies for other diseases including NASH. Other products in the development pipeline include INT-767, a dual FXR/TGR5 agonist, and INT-777, a TGR5 agonist.

Highest paying job titles at Intercept Pharmaceuticals include Regional Business Manager, Patient Access Director, and Medical Director


Market Cap$3.7 billion
Revenue$179.8 million
5 Year Trend+156.4%
Net Income-$309.2 million
Annual Report
Total value of jobs:
Total Jobs:
Average Pay:
Total Experts:
% Masters:

Top Experts at Intercept Pharmaceuticals

Intercept Pharmaceuticals Salaries

Regional Business Manager



Average Salary:$91,604

Patient Access Director



Average Salary:$125,833

Medical Director



Average Salary:$184,286

Account Manager



Average Salary:$125,000

View All Salaries